Xenograft mouse study in C57BL6/SCID mice using A431 cells. Homo sapiens
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
In this study four groups involving, Control arm, Rapamycin arm, Nimotuzumab arm and the Combination group were involved. Four tumors from each group was evaluated for microarray analysis they were the two largest and two smallest from each group. Agilent one-color experiment,Organism: Human ,Agilent-Custom Whole Genome Human 8x60k designed by Genotypic Technology Pvt. Ltd. (AMADID: 027114) , Labeling kit: Agilent Quick-Amp labeling Kit (p/n5190-0442) Overall design: 4 groups: control, rapamycin, nimotuzumab, and rapamycin and nimotuzumab
创建时间：
2011-10-20
